AURX — Nuo Therapeutics Balance Sheet
0.000.00%
- $96.16m
- $95.64m
- $1.37m
- 38
- 21
- 39
- 22
Annual balance sheet for Nuo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.161 | 1.41 | 2.05 | 0.929 | 0.284 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0.092 | 0.251 | 0.248 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.161 | 1.47 | 2.63 | 1.56 | 0.842 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0 | 0.412 | 0.314 | 0.348 |
| Total Assets | 0.161 | 1.47 | 3.05 | 1.88 | 1.19 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.665 | 0.673 | 0.6 | 0.675 | 0.578 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.665 | 0.673 | 0.856 | 0.839 | 0.676 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.504 | 0.793 | 2.19 | 1.04 | 0.514 |
| Total Liabilities & Shareholders' Equity | 0.161 | 1.47 | 3.05 | 1.88 | 1.19 |
| Total Common Shares Outstanding |